Utility of Examination of Biopsy Tracts in Osteosarcoma Resection Specimens.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27543978.
- Also identified by DOI 10.1093/ajcp/aqw119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the utility and necessity of submitting tissue sections from the biopsy tracts of osteosarcoma resection specimens. The prevalence of residual tumor in representative sections of osteosarcoma biopsy tracts was assessed in a series of 97 osteosarcoma resection specimens. No residual tumor cells were identified in 97 sampled biopsy tracts (0%; 95% confidence interval, 0%-2.5%). Pathologists do not need to submit sections of resected biopsy tracts unless there is clinical or gross evidence that would warrant further examination.
Medical subject headings
- Bone Neoplasms
- Neoplasm, Residual
- Osteosarcoma